R1 RCM Inc
NASDAQ:RCM
R1 RCM Inc
Operating Income
R1 RCM Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
R1 RCM Inc
NASDAQ:RCM
|
Operating Income
$260.9m
|
CAGR 3-Years
22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
2%
|
|
DaVita Inc
NYSE:DVA
|
Operating Income
$1.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Operating Income
$1.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
CVS Health Corp
NYSE:CVS
|
Operating Income
$15.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Cigna Corp
NYSE:CI
|
Operating Income
$9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Operating Income
$1.1B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
2%
|
See Also
What is R1 RCM Inc's Operating Income?
Operating Income
260.9m
USD
Based on the financial report for Dec 31, 2023, R1 RCM Inc's Operating Income amounts to 260.9m USD.
What is R1 RCM Inc's Operating Income growth rate?
Operating Income CAGR 10Y
2%
Over the last year, the Operating Income growth was 46%. The average annual Operating Income growth rates for R1 RCM Inc have been 22% over the past three years , and 2% over the past ten years .